Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?

SIMPLE SUMMARY: In the last decade, medulloblastoma entered the molecular era, with progressive advances in the knowledge of the molecular biology of this rare tumor. These expanding data have allowed the recognition of four distinct molecular subgroups, and, subsequently, the design of novel clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Gatto, Lidia, Franceschi, Enrico, Tosoni, Alicia, Di Nunno, Vincenzo, Bartolini, Stefania, Brandes, Alba Ariela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773620/
https://www.ncbi.nlm.nih.gov/pubmed/35053495
http://dx.doi.org/10.3390/cancers14020333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773620/
https://www.ncbi.nlm.nih.gov/pubmed/35053495
http://dx.doi.org/10.3390/cancers14020333

Ejemplares similares